Aptamer Group PLC

27 % revenue surge in H1 2026 for Aptamer Group, driven by new pharma contracts, signals growing commercial traction of its aptamer‑based diagnostics and therapeutics.

Aptamer Group PLC is a pioneering biotechnology company specializing in aptamer technologies, showcasing resilience and innovation in the competitive biotech sector with a market capitalization of £1.7 billion.